Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tests give Fluad the all clear, says Italian agency

This article was originally published in Scrip

Executive Summary

Results of initial tests carried out on the two batches of Novartis' flu vaccine Fluad that were suspended in Italy on 27 November as a result of reports of serious adverse events, including deaths, are "completely negative" and show there is nothing wrong with the quality of the products, says the regulatory agency AIFA.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC027099

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel